A Study of Darvadstrocel for Treating Complex Perianal Fistulas in Children and Teenagers With Crohn's Disease

PHASE3TerminatedINTERVENTIONAL
Enrollment

7

Participants

Timeline

Start Date

June 30, 2021

Primary Completion Date

May 7, 2025

Study Completion Date

May 7, 2025

Conditions
Crohn's DiseaseComplex Perianal Fistula
Interventions
BIOLOGICAL

Darvadstrocel

Darvadstrocel perilesional injection.

Trial Locations (22)

8035

Hospital Universitari Vall d'Hebron, Barcelona

8916

Hospital Universitari Germans Trias i Pujol, Badalona

8950

Hospital Sant Joan de Deu, Barcelona

28009

Hospital Infantil Universitario Nino Jesus, Madrid

28040

Hospital Universitario Fundacion Jimenez Diaz, Madrid

29011

Hospital Materno-Infantil de Malaga, Málaga

91031

Shaare Zedek Medical Center, Jerusalem

3109601

Rambam Health Care Campus, Haifa

4920235

Schneider Children's Medical Center, Petah Tikva

7033001

Shamir Medical Center (Assaf Harofeh), Be’er Ya‘aqov

9124001

Hadassah University Hospital-Mt. Scopus, Jerusalem

113-8431

Juntendo University Hospital, Bunkyō City

113-8519

Medical Hospital, Tokyo Medical and Dental University, Bunkyō City

989-3126

Miyagi Children's Hospital, Sendai

329-0498

Jichi Medical University Hospital, Shimotsuke-shi

514-8507

Mie University Hospital, Tsu

1105 AZ

Amsterdam UMC, Locatie AMC, Amsterdam

9713 GZ

Universitair Medisch Centrum Groningen (UMCG), Groningen

3000 CA

Erasmus Medisch Centrum, Rotterdam

30-663

Uniwersytecki Szpital Dzieciecy w Krakowie, Krakow

35-302

Gabinet Lekarski Bartosz Korczowski, Rzeszów

04-730

"Instytut Pomnik - Centrum Zdrowia Dziecka", Warsaw

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Takeda Development Center Americas, Inc.

INDUSTRY

lead

Takeda

INDUSTRY